RELIABLE BIOPHARMACEUTICAL CORPORATION

Address

RELIABLE BIOPHARMACEUTICAL CORP.
BOX 2517, 1945 WALTON RD
ST. LOUIS, MO, 63114

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. OLIGONUCLEOTIDES AS PRODRUGS FOR ANTICANCER DRUGS

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The overall objected is to develop an easy controlled method of delivery for anticancer nucleoside drugs [cytarabine (araC); cladribine] in their polymeric form as ...

    SBIRPhase I2002Department of Health and Human Services
  2. NEW INOTROPIC AGENTS FOR THE TREATMENT OF HEART FAILURE

    Amount: $134,076.00

    DESCRIPTION (provided by applicant): The goal of the project is to develop new positive inotropes, represented by specifically modified AMP molecules. All of the currently available positive inotropic ...

    STTRPhase I2002Department of Health and Human Services
  3. Synthesis and testing of a new class of heparinoids

    Amount: $587,431.00

    N/A

    SBIRPhase II1997Department of Health and Human Services
  4. Regulators of Fibroblast Growth Factor Activity

    Amount: $50,000.00

    TELEPHONE NUMBER: (314) 429-7700 AWARDEE NUMBER: 1 R43 CA61390-01 The overall objective is to develop polysulfated carbohydrate derivatives that will inhibit the action of fibroblast growth factors (F ...

    SBIRPhase I1993Department of Health and Human Services
  5. Synthesis of Oxidant-Free Potassium Lactobionate

    Amount: $50,000.00

    The overall objective is to develop a process to produce lactobionic acid that is free of oxidizing components. Lactobionic acid is an essential component of perfusion solutions used to preserve organ ...

    SBIRPhase I1993Department of Health and Human Services
  6. SYNTHESIS AND TESTING OF ANTIBIOTIC ANTISENSE CONJUGATES

    Amount: $50,000.00

    THE MAJOR GOAL OF THIS PROJECT IS TO PRODUCE ANTISENSE-OLIGODEOXYNUCLEOTIDES THAT WILL READILY BE TAKEN UP BY TARGET CELLS. TO ACCOMPLISH THIS, WE WILL ATTACH ANTIBIOTICS TO ANTISENSE-OLIGODEOXYNUCLEO ...

    SBIRPhase I1992Department of Health and Human Services
  7. SYNTHESIS AND TESTING OF A NEW CLASS OF HEPARINOIDS

    Amount: $50,000.00

    THE GOAL OF THIS PROJECT IS TO DEVELOP A THERAPEUTIC AGENT WHICH WOULD REPLACE HEPARIN. ALTHOUGH HEPARIN IS THE BEST DRUG FOR TREATMENT OF THROMBOEMBOLIC DISEASE, IT IS UNSTABLE IF ADMINISTERED ORALLY ...

    SBIRPhase I1991Department of Health and Human Services
  8. ISOLATION OF BULK DEOXYNUCLEOSIDES FOR AIDS DRUGS

    Amount: $368,318.00

    SEVERAL EXPERIMENTAL ANTI-VIRAL AIDS DRUGS (AZT, DDC, DDA) ARE BASED ON CHEMICALLY MODIFIED DEOXYNUCLEOSIDES. THESE DEOXYNUCLEOSIDE DERIVATIVES ARE MADE FROM RIBONUCLEOSIDES DUE TO THE UNAVAILABILITY ...

    SBIRPhase II1989Department of Health and Human Services
  9. ISOLATION OF BULK DEOXYNUCLEOSIDES FOR AIDS DRUGS

    Amount: $50,000.00

    N/A

    SBIRPhase I1988Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government